ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PURA Puration Inc (CE)

0.000001
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Puration Inc (CE) USOTC:PURA OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.000001 0.000001 0.000001 5,644 01:00:00

USMJ, PURA and PJET Divide And Conquer To Keep Up With Evolving Cannabis Industry

29/09/2021 7:12pm

InvestorsHub NewsWire


DALLAS, TX -- September 29, 2021 -- InvestorsHub NewsWire -- ACI Conglomerated, the controlling shareholder of North American Cannabis Holdings, Inc. (USOTC: USMJ), Puration, Inc. (USOTC: PURA) and Priority Aviation, Inc. (USOTC: PJET), today issued an update on its plans for the three companies.

ACI has been and continues to execute a series of transactions to update its overall business strategy in keeping with the evolving cannabis sector.
ACI is supporting PURA in the execution of its updated Farmersville Hemp Brand strategy, and likewise supporting USMJ in the execution of its cannabis industry ecommerce strategy.

ACI, in an effort to diversify, is working on the development of a new business initiative outside of the cannabis sector for PJET.  PJET’s new opportunity is advancing on pace, and an announcement is anticipated soon on its new business initiative. 
Contact:

ACI Conglomerated
Steven Rash

info@aciconglomerated.com
+1 (800) 861-1350


Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
 

1 Year Puration (CE) Chart

1 Year Puration (CE) Chart

1 Month Puration (CE) Chart

1 Month Puration (CE) Chart

Your Recent History

Delayed Upgrade Clock